Guggenheim lifts AstraZeneca stock target, buy rating on prospects
Guggenheim adjusted its price target on shares of AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN), increasing it to GBP13,100 from ...
AstraZeneca said to have changed management of its China unit
AstraZeneca (AZN) changes key management roles in China as the company emerges from several scandals involving its executives ...
AZN INVESTOR ALERT: AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
If you suffered substantial losses and wish to serve as lead plaintiff of the AstraZeneca class action lawsuit, please provide your information here: You can also contact attorneys J.C. Sanchez or ...
AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Moody National Bank Trust Division
Moody National Bank Trust Division boosted its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 20.0% during ...
AstraZeneca: Uncertainty Ahead, Neutral Rating Confirmed.
Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...
Why Is AstraZeneca PLC (NASDAQ:AZN) Among the Best FTSE Dividend Stocks to Buy Now?
We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at ...